We examined the abundance of PRMT5 and DAD1 in a range of cell lines derived from CLL and the related mantle cell lymphoma (MCL)20,21 and found them to be expressed at detectable, yet varying levels (Fig. 1e and Supplemental Fig. S2a,b). This evidence concerns the gene PRMT5 and B-cell chronic lymphocytic leukemia.